These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18257895)

  • 1. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
    Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
    Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
    Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
    J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
    Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
    Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group.
    Aybar A; Krause JR
    Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of HLA class I expression by Reed-Sternberg cells.
    Poppema S; Visser L
    Am J Pathol; 1994 Jul; 145(1):37-41. PubMed ID: 7518195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
    Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
    Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgH and TcR-gamma gene rearrangements identified in Hodgkin's disease by PCR demonstrate lack of correlation between genotype, phenotype, and Epstein-Barr virus status.
    Al Saati T; Galoin S; Gravel S; Lamant L; Roda D; Chittal SM; Delsol G
    J Pathol; 1997 Apr; 181(4):387-93. PubMed ID: 9196435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion.
    Ohshima K; Muta K; Nakashima M; Haraoka S; Tutiya T; Suzumiya J; Kawasaki C; Watanabe T; Kikuchi M
    Int J Cancer; 2001 Jul; 93(1):91-6. PubMed ID: 11391627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, expression and function of HLA-G in renal cell carcinoma.
    Seliger B; Schlaf G
    Semin Cancer Biol; 2007 Dec; 17(6):444-50. PubMed ID: 17707652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease.
    Dukers DF; Jaspars LH; Vos W; Oudejans JJ; Hayes D; Cillessen S; Middeldorp JM; Meijer CJ
    J Pathol; 2000 Feb; 190(2):143-9. PubMed ID: 10657011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease.
    Beck A; Päzolt D; Grabenbauer GG; Nicholls JM; Herbst H; Young LS; Niedobitek G
    J Pathol; 2001 Jun; 194(2):145-51. PubMed ID: 11400141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Allele E*01:01 Is Associated with a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02.
    Martín P; Krsnik I; Navarro B; Provencio M; García JF; Bellas C; Vilches C; Gomez-Lozano N
    PLoS One; 2015; 10(8):e0135512. PubMed ID: 26261988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation.
    Pizzato N; Derrien M; Lenfant F
    Hum Immunol; 2004 Nov; 65(11):1389-96. PubMed ID: 15556689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin/Reed-Sternberg cells.
    Di Napoli A; Al-Jadiri MF; Talerico C; Duranti E; Pilozzi E; Trivedi P; Anastasiadou E; Alsaadawi AR; Al-Darraji AF; Al-Hadad SA; Testi AM; Uccini S; Ruco L
    Pediatr Blood Cancer; 2013 Dec; 60(12):2068-72. PubMed ID: 24000236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease.
    Murray PG; Constandinou CM; Crocker J; Young LS; Ambinder RF
    Blood; 1998 Oct; 92(7):2477-83. PubMed ID: 9746788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.